Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › ZLAB

SUPERSTRING CAPITAL MANAGEMENT LP position in ZLAB

Zai Lab Ltd · Health Care

SUPERSTRING CAPITAL MANAGEMENT LP reported holding 155,813 shares of ZLAB (Zai Lab Ltd) in its Q2 2026 13F filing — a position valued at US$3.0M, representing 1.87% of its reported portfolio and ranking #20 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ZLAB holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)155.81K sh
Reported value held$2.96M
Portfolio Weight1.87%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SUPERSTRING CAPITAL MANAGEMENT LP's ZLAB position evolved

SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in ZLAB in Q2 2024 at 215,178 shares (US$3.7M). The position peaked in Q1 2025 at 294,947 shares, worth US$10.7M. Across 9 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 155,813 shares valued at US$3.0M — a reduction of -120,005 shares quarter over quarter.. Notable position changes include a 54% trim in Q3 2024 (shares rose 8% over the following quarter), a 304% increase in Q4 2024 (shares rose 38% over the following quarter), a 54% trim in Q2 2025 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 215.18K $3.73M New
Q3 2024 100.00K $2.41M Reduce
Q4 2024 403.63K $10.57M Add
Q1 2025 294.95K $10.66M Reduce
Q2 2025 134.90K $4.72M Reduce
Q3 2025 200.63K $6.80M Add
Q4 2025 196.85K $3.47M Reduce
Q1 2026 275.82K $5.19M Add
Q2 2026 155.81K $2.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZLAB and 13F data

ZLAB (Zai Lab Ltd) is a Health Care company. 15 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZLAB

All ZLAB fund holders →

FAQ

How long has SUPERSTRING CAPITAL MANAGEMENT LP held ZLAB?

SUPERSTRING CAPITAL MANAGEMENT LP has disclosed ZLAB holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in ZLAB?

As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 155.81K shares of ZLAB (Zai Lab Ltd), valued at $2.96M, representing 1.87% of its reported portfolio and ranking #20.

Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling ZLAB?

In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP reduced its position in ZLAB. The position peaked in Q1 2025 at 294.95K shares.

Which other funds hold ZLAB?

Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.